Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder
NCT01172652 is registered in ClinicalTrials.gov with VA Palo Alto Health Care System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder
- Lead sponsor
- VA Palo Alto Health Care System
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- October 31, 2011
- Enrollment
- 49 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.